Looking for a naltrexone? Not a problem!
Guaranteed Worldwide Shipping
Discreet Package
Low Prices
24/7/365 Customer Support
100% Satisfaction Guaranteed.
Tags:
The FDA announced the approval of a new weight-loss drug on Sept. 11, 2014. The drug name is Contrave.
Using two separate drugs to shed pounds can be very effective there are combinations while watching FDA now awaiting approval. When dealing with weight reduction and the people who go through it you need to err to the side of caution and permit the FDA do its job and demand some research be done so that the public recognizes the side effects and perils associated with the medications before we drive them. Keep in mind that drug companies come in business to generate money and that they would say almost anything to keep people on their own medications.
Researchers discovered that participants investing in this drug to get a year, lost excess weight within one month and have kept the extra weight off through the 56 weeks with the study. Contrave is a combination from the drugs naltrexone and bupropion, which appears to reflect a whole new trend of weight-loss drugs that are made up of many active ingredient, that might make them more efficient and safer.
Combo-pilling may be the newest fad or in addition to this the newest to come under scrutiny and for that reason it is just more publicly known although in the past, comb-pilling to lose weight has been around since the eighties. The biggest reason that by using a combination of pills is now popular may be the fact that since right now there are no long term prescription slimming capsules that have been approved by the FDA other than orlistat. The truly disturbing part is doctors are prescribing these combinations of medications however some of the combinations have been rejected or have yet to be authorized by the FDA.
Seizures can be a side effect with Contrave and really should not be taken in people who have seizure disorders. The drug could also raise blood pressure and heart rate, and mustn’t be used in those with a history of cardiac event or stroke in the previous six months. Blood pressure and pulse should also be measured before beginning the drug and throughout therapy while using drug.
The FDA also warned that Contrave can raise blood pressure and heart rate and must not be used in patients with uncontrolled high blood pressure, as well as by anyone with heart-related and cerebrovascular (circulatory dysfunction impacting the brain) disease. Patients which has a history of cardiac event or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded through the clinical trials. Those taking Contrave needs to have their heart-rate and pulse monitored regularly. In addition, considering that the compound includes bupropion, Contrave comes which has a boxed warning to alert medical researchers and patients towards the increased probability of suicidal thoughts and behaviors connected with antidepressant drugs. The warning also notes that serious neuropsychiatric events have been reported in patients taking bupropion for stopping smoking.
BioCorRx, Inc.’s naltrexone implant is no bigger than a thumb which is inserted underneath the patient’s skin via a 30-minute, non-invasive outpatient procedure created by a healthcare professional. The implant is administered included in BioCorRx, Inc.’s Start Fresh Program which is distributed in a number of states by independent rehabilitation facilities.